Alopecia Universalis and Chronic Graft-vs-Host Disease Treated With Ruxolitinib
This case report describes alopecia universalis and chronic graft-vs-host disease occurring after allogenic hematopoietic stem-cell transplantation and treated with ruxolitinib.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου